Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Gilead Sciences' Trodelvy Gains EU Approval for Breast Cancer

Gilead Sciences' Trodelvy Gains EU Approval for Breast Cancer

MT newswireMT newswire2026/08/24 11:03
07:03 AM EDT, 08/24/2026 (MT Newswires) -- Gilead Sciences (GILD) said Monday that the European Commission approved Trodelvy plus Keytruda for first-line treatment of PD-L1-positive metastatic triple-negative breast cancer. The approval, based on phase 3 data, showed Trodelvy plus Keytruda reduced the risk of disease progression or death by 35% versus standard chemotherapy plus Keytruda. The approval, along with Trodelvy's recent EU authorization as a monotherapy, establishes the drug as a first-line treatment option for metastatic TNBC across PD-L1 status, the company said.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Investors reportedly offering Anthropic allocation shares at premiums of up to 5% ahead of its IPO

According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.

华尔街见闻•2026/11/10 23:03

Nvidia continues to plummet, losing $430 billion in market value over two days, with Microsoft temporarily reclaiming the world's second place.

On Tuesday, Nvidia closed down 5.5%, a decline significantly greater than other major tech stocks, making it a key factor dragging down the tech sector's performance. During intraday trading on Tuesday, Microsoft's market capitalization briefly surpassed Nvidia, making it the world's second largest publicly traded company by market value. However, after Anthropic released its office suite, Microsoft's losses widened, causing it to fall behind Nvidia once again.

华尔街见闻•2026/11/10 23:01
Nvidia continues to plummet, losing $430 billion in market value over two days, with Microsoft temporarily reclaiming the world's second place.